A ray of hope in a dire situation: Radiotherapy for progression after chimeric antigen receptor T-cell therapy
Br J Haematol
.
2020 Jul;190(1):18-19.
doi: 10.1111/bjh.16562.
Epub 2020 Mar 4.
Authors
Rebecca Shakir
1
,
N George Mikhaeel
2
Affiliations
1
Nuffield Department of Population Health, University of Oxford, Oxford, UK.
2
Guy's and St Thomas' NHS Trust and School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
PMID:
32130722
DOI:
10.1111/bjh.16562
No abstract available
Publication types
Comment
MeSH terms
Antigens, CD19
Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive
Lymphoma, Non-Hodgkin*
Receptors, Chimeric Antigen* / genetics
Substances
Antigens, CD19
Receptors, Chimeric Antigen
Grants and funding
21133/CRUK_/Cancer Research UK/United Kingdom
MC_U137686858/MRC_/Medical Research Council/United Kingdom
NIHR300740/DH_/Department of Health/United Kingdom